These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28604434)

  • 21. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
    Baluku M; Wamala T; Muhangi D
    Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.
    Mateu-Gelabert P; Guarino H; Jessell L; Teper A
    J Subst Abuse Treat; 2015 Jan; 48(1):13-20. PubMed ID: 25124258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
    Eckhardt B; Winkelstein ER; Shu MA; Carden MR; McKnight C; Des Jarlais DC; Glesby MJ; Marks K; Edlin BR
    PLoS One; 2017; 12(5):e0177341. PubMed ID: 28542351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
    BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study.
    Kapadia SN; Katzman C; Fong C; Eckhardt BJ; Guarino H; Mateu-Gelabert P
    J Viral Hepat; 2021 Feb; 28(2):326-333. PubMed ID: 33141503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey.
    Lausevic D; Begic S; Mugosa B; Terzic N; Vratnica Z; Labovic I; Bozicevic I
    Harm Reduct J; 2015 Feb; 12():2. PubMed ID: 25884194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between neighborhood socioeconomic disadvantage and high-risk injection behavior among people who inject drugs.
    DeCuir J; Lovasi GS; El-Sayed A; Lewis CF
    Drug Alcohol Depend; 2018 Feb; 183():184-191. PubMed ID: 29288913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012.
    Rivera AV; DeCuir J; Crawford ND; Amesty S; Lewis CF
    Drug Alcohol Depend; 2014 Nov; 144():259-64. PubMed ID: 25307745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Behaviors for HIV and HCV Infection Among People Who Inject Drugs in Hai Phong, Viet Nam, 2014.
    Duong HT; Jarlais DD; Khuat OHT; Arasteh K; Feelemyer J; Khue PM; Giang HT; Laureillard D; Hai VV; Vallo R; Michel L; Moles JP; Nagot N;
    AIDS Behav; 2018 Jul; 22(7):2161-2171. PubMed ID: 28612212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
    Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
    Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
    Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
    Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
    Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
    Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time Since Migration and HIV Risk Behaviors Among Puerto Ricans Who Inject Drugs in New York City.
    Gelpí-Acosta C; Pouget ER; Reilly KH; Hagan H; Neaigus A; Wendel T; Marshall DM
    Subst Use Misuse; 2016 Jun; 51(7):870-81. PubMed ID: 27100322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.
    Heimer R; Eritsyan K; Barbour R; Levina OS
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S12. PubMed ID: 25253447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015.
    Whiteman A; Burnett J; Handanagic S; Wejnert C; Broz D;
    Int J Drug Policy; 2020 Nov; 85():102923. PubMed ID: 32920424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.
    Ruiseñor-Escudero H; Wirtz AL; Berry M; Mfochive-Njindan I; Paikan F; Yousufi HA; Yadav RS; Burnham G; Vu A
    Drug Alcohol Depend; 2014 Oct; 143():127-33. PubMed ID: 25131717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.